The ambulatory surgical centres market size was valued at US$ 96.5 billion in 2023 and is expected to rise at a 4.5% CAGR to reach US$ 150.6 billion by 2033.
The number of ambulatory surgical centres is increasing due to increased demand for inpatient and outpatient care services. The rising costs of healthcare at general hospitals have increased the public’s preference for ASCs for high-quality healthcare services.
Get a Sample Copy of the Report :https://www.futuremarketinsights.com/reports/sample/rep-gb-5071
The ASCs offer adequate treatments to cure illnesses, along with providing many facilities including reimbursement policies and insurance options. Thus, providing a cost-effective treatment to patients, lower than the expenses incurred at hospitals.
At ASCs, physicians are in a better position to control expenses and patient experience. By concentrating on one specialty and owning the equipment, it becomes easier for healthcare providers to schedule procedures and run an operating room efficiently. Therefore, more physicians are opening up ASCs to cater to the growing demand for surgical procedures. Going forward, the ambulatory surgical centers market is being governed by the research and development activities initiated by key players for the advancement of the market.
Key Takeaways from the Ambulatory Surgical Centers Market:
- The U.S. market is predicted to maintain its prominent position over the forecast period as well, and reach US$ 73.5 billion by 2033. The market is predicted to record a CAGR of 4.5% from 2023 to 2033.
- In Asia Pacific, Japan is estimated to attain US$ 5.7 billion by 2033. The market valuation of Japan is significant than China, which attained US$ 5.3 billion in the same year.
- However, the growth of the market in China is projected to be 5% CAGR, greater than the 2.4% CAGR estimated for the market in Japan.
- Over the forecast period, the surgical services segment is projected to emerge as the leading service, recording a CAGR of 4.6%.The
- Increasing number of ASCs delivering high-quality outpatient surgical care is projected to contribute towards the progress of this segment.
Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5071
News Featuring Market Developments by Key Players of Ambulatory Surgical Centers:
- In January 2023, Hudson Medical Center, a US$50 million and 1, 60,000 square foot facility, opened its gates for patients. At the same premises, the first ASC in St. Croix County, named Valley Surgery Center, will also be present. The center will be able to operate about 10,000 surgeries every year, after its commencement.
- In August 2022, HCA Healthcare, a major healthcare provider in the U.S., announced its acquisition of Stone Oak Surgery Center, in association with 11 physician partners. The latter is a San Antonio-based ASC, authorized by the Centers for Medicare & Medicaid Services (CMS), and offers multispecialty services. With this acquisition, HCA Healthcare will extend its footprint in San Antonio.
- Earlier, in January 2022, the company had revealed its decision to develop five new hospitals, offering all the necessary services in Texas. With this initiative, the company aims to cater to the rising need for healthcare services in the state.
Key Companies:
- AmSurg Corp
- Tenet Healthcare
- HCA Holdings, Inc.
- Surgical Care Affiliates, Inc.
- Surgery Partners
- Ambulatory Surgical Centers of America
- Pinnacle III
- Proliance Surgeons
- Regent Surgical Health
- SurgCenter Development
Ambulatory Surgical Centers Market by Category
By Centers Type:
- Single Specialty Centers
- MultiSpecialty Centers
By Modality:
- Hospital-Based Ambulatory Surgical Center
- Freestanding Ambulatory Surgical Center
By Services:
- Diagnostic Services
- Surgical Services
By Specialty Area:
- Gastroenterology
- Ophthalmology
- Orthopedics
- Pain/Neurology
- Urology
- Dermatology
- Others
Unlock Tailored Insights: Customize Your Report for Maximum Impact :https://www.futuremarketinsights.com/customization-available/rep-gb-5071
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube